For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza

Advice about Adverse Event (Side Effects) Reporting

At Cadila Pharmaceuticals, we are committed to providing world class medicines at affordable cost to the last man standing in society. We understand the need and importance of monitoring drug safety – right from the discovery of the medicine to the entire life cycle of the drug. Cadila Pharmaceuticals tries to ensure that correct information regarding safe and rational use of medicines is assimilated to the public


If you wish to report an adverse event occurring with any of our drug, please read below:

What to report:

All types of adverse events (side effects occurring after administration of drug)

Other scenario/situations (even if not associated with adverse event)

  • Overdose
  • Accidental use
  • Abuse and misuse
  • Medication errors
  • Use of drug during pregnancy
  • Use of drug during breast feeding
  • Paternal exposure
  • Drug interactions
  • Lack of efficacy
  • Unexpected therapeutic or clinical benefit
  • Use of drug in unapproved indication

Where to report:
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.
Phone : +91-2718-225001
Fax : +91-2718-225039

E-mails

i) For Global PV Reporting (Except US & Europe): Safety.cadila.global@cadilapharma.co.in

ii) For PV Reporting in US: Safety.cadila.us@cadilapharma.co.in

iii) For PV Reporting in Europe: Safety.cadila.uk@cadilapharma.co.in

iv) For detailed reporting click to download Adverse Event Reporting Form

Report even if:

You are not certain whether the medicine caused an adverse reaction or not

You don’t have all the required details

Confidentiality:

All the information and personal data you share with us will be protected and kept confidential in line with company’s policies. The information you provide will be used for the purpose of drug safety surveillance and it may be shared with health authorities. You have the right of access to your personal data which we have. Submission of a report does not constitute an admission that medical personnel or manufacturer of the product caused or contributed to the reaction.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2017 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals